Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.285
-0.025 (-1.91%)
Sep 16, 2026, 3:45 PM EDT - Market open
Geron Revenue
Geron had revenue of $57.48M in the quarter ending June 30, 2026, with 17.22% growth. This brings the company's revenue in the last twelve months to $204.56M, up 24.39% year-over-year. In the year 2025, Geron had annual revenue of $183.88M with 138.83% growth.
Revenue (ttm)
$204.56M
Revenue Growth
+24.39%
P/S Ratio
4.04
Revenue / Employee
$792,864
Employees
258
Market Cap
825.58M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 183.88M | 106.89M | 138.83% |
| Dec 31, 2024 | 76.99M | 76.76M | 32,386.92% |
| Dec 31, 2023 | 237.00K | -359.00K | -60.23% |
| Dec 31, 2022 | 596.00K | -797.00K | -57.21% |
| Dec 31, 2021 | 1.39M | 1.14M | 450.59% |
| Dec 31, 2020 | 253.00K | -207.00K | -45.00% |
| Dec 31, 2019 | 460.00K | -606.00K | -56.85% |
| Dec 31, 2018 | 1.07M | 1.00K | 0.09% |
| Dec 31, 2017 | 1.07M | -5.10M | -82.72% |
| Dec 31, 2016 | 6.16M | -30.21M | -83.06% |
| Dec 31, 2015 | 36.37M | 35.22M | 3,054.47% |
| Dec 31, 2014 | 1.15M | -130.00K | -10.13% |
| Dec 31, 2013 | 1.28M | -1.43M | -52.64% |
| Dec 31, 2012 | 2.71M | 271.00K | 11.12% |
| Dec 31, 2011 | 2.44M | -1.13M | -31.57% |
| Dec 31, 2010 | 3.56M | 1.84M | 106.43% |
| Dec 31, 2009 | 1.73M | -1.08M | -38.42% |
| Dec 31, 2008 | 2.80M | -4.82M | -63.22% |
| Dec 31, 2007 | 7.62M | 4.35M | 132.59% |
| Dec 31, 2006 | 3.28M | -2.88M | -46.78% |
| Dec 31, 2005 | 6.16M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 450.89M |
| Rigel Pharmaceuticals | 276.79M |
| Theravance Biopharma | 104.31M |
| Wave Life Sciences | 65.37M |
| Lexicon Pharmaceuticals | 41.47M |
| Crescent Biopharma | 11.88M |
| Avalo Therapeutics | 59.00K |
GERN News
- 1 day ago - Geron Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 2 days ago - Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN - Business Wire
- 7 days ago - Geron Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 13 days ago - Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 14 days ago - Geron to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Geron Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Geron Earnings release: Q2 2026 - Filings